Skip to main content
Toggle navigation
Search
Home
Browse by Poster Title
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Title
Browse by Poster Title
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Sort by
NUM
Sort by
Title
"
Favorite
29
"No-Option” Malignant Vertebra Plana: Technical Pearls and Updated Outcomes After Salvage RFA + Kyphoplasty
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
A
Favorite
24
A Case Report of Successful Treatment of Metastatic Liposarcoma with Pulsed Electric Fields
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
B
Favorite
9
Bowel Complication following Combined (TACE+Y90) Liver Directed Therapy
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
C
Favorite
27
Concurrent Liver Ablation and Paracentesis in Patients with Preexisting Ascites
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
E
Favorite
23
Efficacy and Safety of Intraarterial Chemotherapy in Locally Aggressive Breast Cancers: A 10-Year Literature Review
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
Favorite
3
Enhancing Treatment of Hepatocellular Carcinoma with Cowpea Mosaic Virus as an Adjuvant Therapy
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
F
Favorite
2
Feasibility of CT Based Tumor Dosimetry Using Multimodal Imageable Glass Eye90 microspheres®
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
Favorite
10
Final Results of the GPX Embolic Device Multi-Center Trial for Distal Applications
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
Favorite
1
Four-year Overall Survival from the HIMALAYA Study of Tremelimumab + Durvalumab in Unresectable Hepatocellular Carcinoma
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
I
Favorite
13
IMbrave050: Phase 3 study of adjuvant atezolizumab + bevacizumab vs surveillance in hepatocellular carcinoma patients
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
Favorite
6
Interventional Oncology Procedures with Adjuvant Adoptive Cell Therapy in the Treatment of Hepatocellular Carcinoma
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
M
Favorite
17
Multimodal Management of CRC Liver Metastases with Hepatectomy and Microwave Ablation
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
N
Favorite
14
Not novel, but effective! Sclerotherapy for Aneurysmal Bone Cyst
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
P
Favorite
30
Palliative Ablation and Kyphoplasty for a Suspected Metastatic Fracture
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
Favorite
35
Percutaneous Ablation of Colorectal Liver Metastasis in a Patient with Hereditary Hemorrhagic Telangiectasia
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
Favorite
18
Pulsed Electric Field Therapy Enhances Survival in Murine Breast Cancer Models Relative to Thermal Ablation
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
R
Favorite
34
Radioembolization plus Gemcitabine, Cisplatin and Capecitabine as First-Line Therapy for Intrahepatic Cholangiocarcinoma
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
Favorite
28
Rapid extra segmental metastases of Hepatocellular Carcinoma following Transarterial Chemoembolization: Two Cases
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
Favorite
25
Rare Instance of Uterine Leiomyomatosis Vascular Extension Into the Cavoatrial Junction
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
S
Favorite
7
Socioeconomic and Demographic Predictors of Transarterial Chemoembolization Outcomes for Hepatic Malignancies
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
Favorite
15
Survival Outcomes for Yttrium-90 Radioembolization to Treat Unresectable Intrahepatic Cholangiocarcinoma
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
T
Favorite
26
The Cost of Catheter Dislodgement
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
Favorite
31
Thyroid Ablation after Thyroid Cancer Recurrence in a Hostile Neck
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
Favorite
32
Transradial versus Transfemoral Access for Interventional Oncology Procedures: A Systematic Review and Meta-Analysis
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
Favorite
16
Treating Hepatic Tumors with Histotripsy: Insights from the THERESA Trial and Literature Review
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
Favorite
33
Tumor Size and Watershed Area Correlates in Progression of Hepatocellular Carcinoma after Segmental Radioembolization
Saturday, September 23, 2023
6:00 PM – 7:30 PM
East Coast USA Time
